Diagnostic utility of CD10 in benign and malignant extrahepatic bile duct lesions

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 101-108

  Tretiakova, Maria ^a   Antic, Tatjana ^a   Westerhoff, Maria ^a   Mueller, Jeffrey ^a   Himmelfarb, Eric A ^b   Wang, Hanlin L ^b   Xiao, Shu Yuan ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

bile duct; biopsy; CD10

Indexed keywords

MEMBRANE METALLOENDOPEPTIDASE; TUMOR MARKER;

AGED; ARTICLE; BILE DUCT DISEASE; BILE DUCT TUMOR; BIOSYNTHESIS; FEMALE; HEPATIC DUCT; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY;

AGED; BILE DUCT DISEASES; BILE DUCT NEOPLASMS; BILE DUCTS, EXTRAHEPATIC; BIOPSY, FINE-NEEDLE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEPRILYSIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84355162960     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822fbc95     Document Type: Article

References (37)

1. Adsay VN. Gallbladder, extrahepatic biliary tree, and ampulla. In: Mills SE, Carter D, Greenson JK, et al, eds. Sternberg's Diagnostic Surgical Pathology. Lippincott Williams & Wilkins: Philadelphia, PA; 2009:1601.
2. Argani P, Iacobuzio-Donahue C, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res.7; 2001: 3862-3868. (Pubitemid 34044602)
3. Borscheri N, Roessner A, Rocken C. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol. 2001;25:1297-1303. (Pubitemid 32917124)
4. Byrne JA, Meara NJ, Rayner AC, et al. Lack of hepatocellular CD10 along bile canaliculi is physiologic in early childhood and persistent in Alagille syndrome. Lab Invest. 2007;87:1138-1148. (Pubitemid 47609029)
5. Carvalho KM, Nava RA, Franca MS, et al. A liver metalloendo-peptidase which degrades the circulating hypotensive peptide hormones bradykinin and atrial natriuretic peptide. Braz J Med Biol Res. 1999;32:51-54. (Pubitemid 129591671)
6. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms: frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113:374-382. (Pubitemid 30217385)
7. Cohen AJ, Franklin WA, Magill C, et al. Low neutral endopepti-dase levels in bronchoalveolar lavage fluid of lung cancer patients. Am J Respir Crit Care Med. 1999;159:907-910. (Pubitemid 29137794)
8. D'Adamio L, Shipp MA, Masteller EL, et al. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24. 11): multiple miniexons and separate 5 untranslated regions. Proc Natl Acad Sci USA. 1989;86:7103-7107. (Pubitemid 19240873)
9. DeOliveira ML, Cunningham SC, Cameron JL, et al. Cholangio-carcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007;245:755-762. (Pubitemid 46684105)
10. Fiori E, Macchiarelli G, Schillaci A, et al. Hepatocyte ultrastructural aspects after preoperative biliary drainage in pancreatic cancer patients with cholestatic jaundice. Anticancer Res. 2003;23:4859-4863. (Pubitemid 38173906)
11. Gohring B, Holzhausen HJ, Meye A, et al. Endopeptidase 24.11/CD10 is down-regulated in renal cell cancer. Int J Mol Med. 1998;2: 409-414.
12. Greaves MF, Brown G, Rapson NT, et al. Antisera to acute lympho-blastic leukemia cells. Clin Immunol Immunopathol. 1975;4:67-84.
13. Grogan TM, Verdi C. The expression of common acute lympho-blastic leukemia antigen by bile canaliculi. N Engl J Med. 1985;312:993-994. (Pubitemid 15111967)
14. Groisman GM, Amar M, Livne E. CD10: a valuable tool for the light microscopic diagnosis of microvillous inclusion disease (familial microvillous atrophy). Am J Surg Pathol. 2002;26:902-907. (Pubitemid 34747642)
15. Hassan R, Laszik ZG, Lerner M, et al. Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis. Am J Clin Pathol. 2005;124:838-845. (Pubitemid 41740183)
16. Ikenaga N, Ohuchida K, Mizumoto K, et al. CD10+ pancreatic stellate cells enhance the progression of pancreatic cancer. Gastro-enterology. 2010;139:1041-1051, 1051.e1-1051.e8.
17. Karamitopoulou E, Tornillo L, Zlobec I, et al. Clinical significance of cell cycle-and apoptosis-related markers in biliary tract cancer: a tissue microarray-based approach revealing a distinctive immuno-phenotype for intrahepatic and extrahepatic cholangiocarcinomas. Am J Clin Pathol. 2008;130:780-786.
18. Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47:1544-1556. (Pubitemid 351702738)
19. Lau SK, Prakash S, Geller SA, et al. Comparative immunohisto-chemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33:1175-1181. (Pubitemid 36020066)
20. Levy M, Lin F, Xu H, et al. S100P, von Hippel-Lindau gene product, and IMP3 serve as a useful immunohistochemical panel in the diagnosis of adenocarcinoma on endoscopic bile duct biopsy. Hum Pathol. 2010;41:1210-1219.
21. Loke SL, Leung CY, Chiu KY, et al. Localisation of CD10 to biliary canaliculi by immunoelectron microscopical examination. J Clin Pathol. 1990;43:654-656. (Pubitemid 20228926)
22. McIntosh GG, Lodge AJ, Watson P, et al. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. Am J Pathol. 1999;154:77-82. (Pubitemid 29031614)
23. Morrison C, Marsh W Jr, Frankel WL. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver. Mod Pathol. 2002;15:1279-1287. (Pubitemid 35462995)
24. Nagata S, Ajioka Y, Nishikura K, et al. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10. Oncol Rep. 2007;17:721-729.
25. Nishihara Y, Aishima S, Hayashi A, et al. CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangio-carcinoma than of peripheral intrahepatic cholangiocarcinoma. Histopathology. 2009;55:423-431.
26. Obama K, Ura K, Li M, et al. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology. 2005;41:1339-1348. (Pubitemid 40770287)
27. Papandreou CN, Usmani B, Geng Y, et al. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med. 1998;4:50-57. (Pubitemid 28133079)
28. Pekonen F, Nyman T, Ammala M, et al. Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Br J Cancer. 1995;71: 59-63.
29. Rocken C, Licht J, Roessner A, et al. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocel-lular carcinoma. J Clin Pathol. 2005;58:1069-1075. (Pubitemid 41416057)
30. Scoazec JY, Bringuier AF, Medina JF, et al. The plasma membrane polarity of human biliary epithelial cells: in situ immunohistochem-ical analysis and functional implications. J Hepatol. 1997;26: 543-553. (Pubitemid 27112719)
31. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24:115-125. (Pubitemid 38738341)
32. Shousha S, Gadir F, Peston D, et al. CD10 immunostaining of bile canaliculi in liver biopsies: change of staining pattern with the development of cirrhosis. Histopathology. 2004;45:335-342. (Pubitemid 39430638)
33. Stitnimankarn T, Thakerngpol K, Damrongsak C, et al. Ultrastructure of cholangiocarcinoma associated with opisthor-chiasis. Southeast Asian J Trop Med Public Health. 1978;9: 558-567.
34. Swierczynski SL, Maitra A, Abraham SC, et al. Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays. Hum Pathol. 2004;35:357-366. (Pubitemid 38339611)
35. Tan G, Yilmaz A, De Young BR, et al. Immunohistochemical analysis of biliary tract lesions. Appl Immunohistochem Mol Morphol. 2004;12:193-197.
36. Xiao SY, Wang HL, Hart J, et al. cDNA arrays and immunohis-tochemistry identification of CD10/CALLA expression in hepato-cellular carcinoma. Am J Pathol. 2001;159:1415-1421. (Pubitemid 32947971)
37. Zheng S, Luo Y, Wang W, et al. Analysis of the pathomorphology of the intra-and extrahepatic biliary system in biliary atresia. Eur J Pediatr Surg. 2008;18:98-102. (Pubitemid 351702863)